Two analysts following hospital industry leader HCA Holdings have hiked their price targets for the company following its Q2 profit report. At Oppenheimer, Michael Wiederhorn now sees HCA — which ended Tuesday trading at $65.07 (Ticker: HCA) — climbing to $74 in the coming quarter. That's up from $62. Ann Hynes at Mizuho has him beat by a dollar after lifting her target to $75 from $60. Both analysts recommend investors add to their HCA holdings.
POSTDATA: WARRANTY DEEDS